Market watch: The impact of consumer-directed health plans on prescription drug use

Health Affairs

Volumn 27, Issue 4, 2008, Pages 1111-1119

  Greene, Jessica ^a   Hibbard, Judith ^a   Murray, James F ^b   Teutsch, Steven M ^b   Berger, Marc L ^c  

^a UNIVERSITY OF OREGON   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIULCER AGENT; GENERIC DRUG; PRESCRIPTION DRUG; UNCLASSIFIED DRUG;

ARTICLE; CONSUMER HEALTH INFORMATION; DRUG INDUSTRY; DRUG USE; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; MALE; PHARMACY; PRESCRIPTION; CONSUMER; COST; ECONOMICS; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; UNITED STATES;

CONSUMER PARTICIPATION; DEDUCTIBLES AND COINSURANCE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAL SAVINGS ACCOUNTS; ORGANIZATIONAL CASE STUDIES; PRESCRIPTION DRUGS; UNITED STATES;

EID: 48149095676     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.4.1111     Document Type: Article

References (29)

1. J.C. Robinson, "Health Savings Accounts - The Ownership Society in Health Care," New England Journal of Medicine 353, no. 12 (2005): 1199-1202.
2. American Association of Preferred Provider Organizations, "2008 Survey of Consumer-Directed Health Plans," http://aappo.org/index.cfm?page id=18 (accessed 27 March 2008); and M. Rosenthal and A. Milstein, "Consumer-Directed Health Plans: Diffusion and Cross-Fertilization in the Marketplace" (Unpublished manuscript, Harvard University, 2005).
3. R. Herzlinger, "Let's Put Consumers in Charge of Health Care," Harvard Business Review 80, no. 7 (2002): 44-55;
4. and G. Scandlen, "Commentary - How Consumer-Driven Health Care Evolves in a Dynamic Market," Health Services Research 39, no. 4, Part 2 (2004): 1113-1118;
5. K. Davis, "Consumer-Directed Health Care: Will It Improve Health System Performance?" Health Services Research 39, no. 4, Part 2 (2004): 1219-1234;
6. and M.B. Buntin et al., " 'Consumer-Directed' Health Plans: Implications for Health Care Quality and Cost" (Oakland: California HealthCare Foundation, 2005).
7. J.P. Newhouse and the Insurance Experiment Group, Free for All? Lessons from the RAND Health Insurance Experiment (Cambridge, Mass.: Harvard University Press, 1993).
8. S.T. Parente, R. Feldman, and J.B. Christianson, "Evaluation of the Effect of a Consumer-Driven Health Plan on Medical Care Expenditures and Utilization," Health Services Research 39, no. 4, Part 2 (2004): 1189-1210;
9. V. Agrawal et al., Consumer-Directed Health Plan Report - Early Evidence Is Promising (Pittsburgh: McKinsey and Company, 2005);
10. and P. Fronstin and S. Collins, Early Experience with High-Deductible and Consumer-Driven Health Plans: Findings from the EBRI/Commonwealth Fund Consumerism in Health Care Survey, Issue Brief no. 288 (New York: Commonwealth Fund, 2005).
11. Parente et al., "Evaluation of the Effect."
12. T.B. Gibson, R.J. Ozminkowski, and R.Z. Goetzel, "The Effects of Prescription Drug Cost Sharing: A Review of the Evidence," American Journal of Managed Care 11, no. 11 (2005): 730-740.
13. R. Tamblyn et al., "Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons," Journal of the American Medical Association 285, no. 4 (2001): 421-429;
14. and M. Gaynor, J. Li, and W. Vogt, "Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits," NBER Working Paper no. 12758 (Cambridge, Mass.: National Bureau of Economic Research, 2006).
15. Health reimbursement arrangement (HRA) plans differ most notably from health savings accounts (HSAs) in that HRAs are exclusively funded by the employer and revert to the employer upon the employee's termination. In contrast, employees own HSAs, and they are portable to different places of employment.
16. G. Claxton et al., Employer Health Benefits: 2005 Annual Survey (Menlo Park, Calif.: Henry J. Kaiser Family Foundation, 2007).
17. The out-of-pocket costs were half as high for those with individual coverage (deductible of $1,500 and a personal spending account of $750).
18. In 2003 the copayments were $8, $15, and $22, respectively, for generic, preferred, and nonpreferred drugs. These sizable increases may reduce the CDHP impact that we observed in this study.
19. For more detail on how the plan designs influenced out-of-pocket pharmacy costs, see online Appendix 1, at http://content.healthaffairs.org/cgi/content/ full/27/4/1111/DC1.
20. J. Greene et al., "Which Consumers Are Ready for Consumer-Directed Health Plans?" Journal of Consumer Policy 29, no. 3 (2006): 247-262.
21. 2004 Red Book Update (Montvale, N.J.: Medical Economics Co., 2004).
22. H. Quan, G.A. Parsons, and W.A. Ghali, "Validity of Information on Comorbidity Derived from ICD-9-CCM Administrative Data," Medical Care 40, no. 8 (2002): 675-685.
23. More detail on the propensity score approach is available in online Appendix 2, as in Note 14.
24. We also ran the models with salary grade, a more refined measure of income than employee type. The results were consistent with findings presented here, but because it was not available for all subjects, we have presented findings with employee type.
25. The full model is available in online Appendix 3, as in Note 14.
26. T.B. Gibson et al., "Impact of Statin Copayments on Adherence and Medical Care Utilization and Expenditures," American Journal of Managed Care 12, Special Issue (2006): SP11-SP19;
27. and J.M. Stephens, M.F. Botteman, and J.W. Hay, "Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature," Journal of Managed Care Pharmacy 12, no. 2 (2006): 130-142.
28. A. Dixon, J. Greene, and J. Hibbard, "Do Consumer-Directed Health Plans Drive Change in Enrollees' Health Care Behavior?" Health Affairs 27, no. 4 (2008): 1120-1131.
29. M.E. Chernew et al., "Impact of Decreasing Copayments on Medication Adherence within a Disease Management Environment," Health Affairs 27, no. 1 (2008): 103-112.